Roxwood Medical
Boston Scientific makes $4.2bn play for UK’s BTG
Comes shortly after the company acquired US biotech Augmentix
AstraZeneca and BGT shelve experimental sepsis drug
Decision follows CytoFab’s poor mid-stage clinical trial results
Comes shortly after the company acquired US biotech Augmentix
Decision follows CytoFab’s poor mid-stage clinical trial results